≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Mental and behavioural disorders associated with the puerperium

DOID Endpoint Browser

F5_MENTPUER

postpartum depression: An endogenous depression that involves intense, sustained and sometimes disabling depression experienced by women after giving birth.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F53
  • Hospital discharge: ICD-8 — 2944
  • Cause of death: ICD-10 — F53
  • Cause of death: ICD-8 — 2944

2 out of 7 registries used, show all original rules.

425

4. Check minimum number of events

None

425

5. Include endpoints

None

425

6. Filter based on genotype QC (FinnGen only)

425

Control definitions (FinnGen only)

Control exclude
F5_BEHAVE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F50-F59
Name in latin
Perturbationes mentis et modi se gerendi puerperio adjunctae non alibi classificatae

Similar endpoints

↥

List of similar endpoints to Mental and behavioural disorders associated with the puerperium based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 425 425 -
Unadjusted period prevalence (%) 0.14 0.14 -
Median age at first event (years) 30.32 30.32 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
388
Matched controls
3880
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F53.0
ICD-10 Finland
Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified
2851.3
186.1
165
*
F53.1
ICD-10 Finland
Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified
+∞
123.7
112
*
29440
ICD-8 Finland
Psychosis associated with other physical conditions, Childbirth
+∞
80.0
74
*
N05AH04
ATC
quetiapine; oral
8.8
74.1
196
404
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
15.5
74.1
130
122
F53.9
ICD-10 Finland
Puerperal mental disorder, unspecified
+∞
65.5
61
*
N05AH03
ATC
olanzapine; systemic
14.1
57.9
104
98
N05BA04
ATC
oxazepam; oral
5.5
51.3
205
652
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
15.8
44.7
75
58
F29
ICD-10 Finland
Unspecified nonorganic psychosis
14.5
42.0
73
61
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.4
37.5
132
338
N06AB06
ATC
sertraline; oral
5.6
33.9
112
262
N05AX08
ATC
risperidone; systemic
8.8
32.5
73
99
N05AX12
ATC
aripiprazole; systemic
9.6
30.3
64
78
N03AG01
ATC
valproic acid; systemic, rectal
7.3
28.2
72
118
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
12.3
26.7
49
45
N05AB03
ATC
perphenazine; systemic, rectal
11.1
26.4
51
52
N05AA02
ATC
levomepromazine; systemic
13.6
25.8
45
37
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.8
24.9
93
241
N06AB04
ATC
citalopram; systemic
3.6
24.9
139
521
N05AN01
ATC
lithium; oral
12.9
24.7
44
38
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.3
23.8
101
296
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
12.6
22.8
41
36
N05CD07
ATC
temazepam; oral
6.1
21.7
62
117
N05AA01
ATC
chlorpromazine; systemic, rectal
28.3
21.7
29
11
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.4
21.2
68
148
N06AX11
ATC
mirtazapine; oral
3.0
21.1
165
767
N05BA06
ATC
lorazepam; systemic, sublingual
9.4
21.0
44
52
O99.80
ICD-10 Finland
The fear of childbirth
4.5
20.2
78
206
N05AD01
ATC
haloperidol; systemic
16.5
20.1
32
21
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
12.3
19.9
36
32
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
9.3
18.7
39
46
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
17.3
18.6
29
18
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
10.3
18.3
36
38
F53.8
ICD-10 Finland
Other mental and behavioural disorders associated with the puerperium, not elsewhere classified
+∞
17.8
17
*
N05AC02
ATC
thioridazine; oral
14.0
17.8
30
23
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.7
17.6
52
102
N04AA02
ATC
biperiden; systemic
18.5
17.2
26
15
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
7.4
17.0
41
61
N05CF01
ATC
zopiclone; oral
2.8
16.8
136
628
P76
ICPC
Depressive disorder
4.4
16.7
64
167
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.8
16.5
77
240
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.4
16.5
63
164
N06AX16
ATC
venlafaxine; oral
3.2
16.3
100
383
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
25.8
16.2
22
9
ZY000
NOMESCO Finland
Hospital inpatient
15.6
15.6
25
17
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.7
15.0
53
127
N06AB03
ATC
fluoxetine; oral
3.4
15.0
81
282
P29
ICPC
Psychological sympt/compl other
4.5
14.3
53
133
N06AB05
ATC
paroxetine; oral
4.6
13.9
49
117
N05AF03
ATC
chlorprothixene; systemic
8.0
13.4
30
40
Z2446
NOMESCO Finland
Social worker
4.5
13.4
48
117
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
14.7
12.9
21
15
N03AX09
ATC
lamotrigine; oral
4.2
12.7
49
128
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
+∞
12.6
12
*
P01
ICPC
Feeling anxious/nervous/tense
2.8
12.3
90
381
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.6
12.1
102
469
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
2.1
11.9
206
1339
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.3
11.9
36
73
IGY02
NOMESCO Finland
Psychiatric monitoring contact
7.1
11.7
28
42
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
10.1
11.4
22
23
F20.9
ICD-10 Finland
Schizophrenia, unspecified
10.0
10.9
21
22
SPAT1240
SPAT
Therapeutic discussion
2.7
10.8
82
354
F51.0
ICD-10 Finland
Nonorganic insomnia
2.7
10.8
78
326
P99
ICPC
Psychological disorders other
5.9
10.6
29
52
F31.8
ICD-10 Finland
Other bipolar affective disorders
6.7
10.5
26
41
ZY010
NOMESCO Finland
Hospital outpatient
3.8
10.4
44
125
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
2.1
9.9
147
876
29999
ICD-8 Finland
Unspecified psychosis
56.4
9.7
11
*
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
6.0
9.7
26
46
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
8.7
9.7
20
24
N06AB10
ATC
escitalopram; oral
2.2
9.6
123
684
N06AA12
ATC
doxepin; systemic
5.4
9.6
28
55
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.7
9.6
68
279
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
18.1
9.5
14
8
P06
ICPC
Sleep disturbance
3.0
9.5
57
211
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
12.8
9.4
16
13
O80.0
ICD-10 Finland
Spontaneous vertex delivery
2.0
9.4
211
1467
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.5
9.1
26
50
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
5.9
8.6
23
41
P74
ICPC
Anxiety disorder/anxiety state
3.8
8.5
35
98
R3110
NOMESCO Finland
Psychosocial training
5.3
8.5
25
50
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
7.0
8.5
20
30
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
8.1
8.5
18
23
G02CB01
ATC
bromocriptine; systemic
6.1
8.4
22
38
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
14.9
8.3
13
9
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.3
8.2
81
399
N05BA12
ATC
alprazolam; oral
2.8
8.2
52
201
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
12.0
8.1
14
12
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
34.1
8.1
10
*
P72
ICPC
Schizophrenia
8.0
8.0
17
22
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.9
7.9
21
37
T90
ICPC
Diabetes non-insulin dependent
2.7
7.9
56
231
N06AX12
ATC
bupropion; oral
2.8
7.7
49
189
N05AF05
ATC
zuclopenthixol; systemic
12.2
7.6
13
11
188
Kela drug reimbursment
Psychosis requiring demanding treatment
10.3
7.6
14
14
ZYC01
NOMESCO Finland
Remote contact by phone
3.7
7.5
31
88
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
5.8
7.5
20
36
F31.21
ICD-10 Finland
Bipolar disorder, manic episode with mood incongruent psychotic symptoms
81.6
7.4
8
*
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
13.7
7.4
12
9
N05BA01
ATC
diazepam; systemic, rectal
2.6
7.3
53
222
P98
ICPC
Psychosis NOS/other
16.1
7.3
11
7
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.5
7.3
16
22
P73
ICPC
Affective psychosis
30.6
7.2
9
*
SPAT1389
SPAT
Visit based on need for special support
4.5
7.2
24
56
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.4
7.2
34
108
SPAT1241
SPAT
Extensive assessment of psychosocial situation
9.0
7.1
14
16
F31
ICD-10 Finland
Bipolar affective disorder
9.0
7.1
14
16
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.6
7.1
23
52
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
7.2
7.1
16
23
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.9
7.0
41
150
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
1.8
7.0
138
892
A06AD11
ATC
lactulose; oral
3.0
7.0
40
145
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.6
6.9
29
84
N05CF02
ATC
zolpidem; oral
2.1
6.8
81
430
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.2
6.8
34
113
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
2.0
6.6
89
496
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
8.9
6.6
13
15
W78
ICPC
Pregnancy
1.8
6.6
132
853
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.3
6.5
31
99
N06AX03
ATC
mianserin; oral
3.8
6.5
26
72
N05BE01
ATC
buspirone; oral
5.1
6.4
19
39
29580
ICD-8 Finland
Schizophrenia, Other
71.0
6.4
7
*
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
71.0
6.4
7
*
Z2445
NOMESCO Finland
Psychologist
3.6
6.4
27
79
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.0
6.3
82
452
IGP01
NOMESCO Finland
Psychiatric family contact
18.4
6.3
9
5
F28
ICD-10 Finland
Other nonorganic psychotic disorders
18.4
6.3
9
5
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
27.1
6.2
8
*
N06AA22
ATC
NA
27.1
6.2
8
*
2954A
ICD-9 Finland
Schizophrenic psychoses, Acute schizophrenic episode
27.1
6.2
8
*
N06AB08
ATC
fluvoxamine; oral
5.5
6.2
17
32
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.4
6.2
21
50
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
2.1
6.2
79
430
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
2.2
6.2
63
310
N06AX05
ATC
trazodone; oral
5.7
6.1
16
29

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
106
465
2.70
16.08
1.8
1.5
%
1.4
1.3
2.26
96
423
(3015377) Calcium [Moles/volume] in Serum or Plasma
171
973
2.27
14.45
2.5
2.8
mmol/l
2.3
2.3
0.53
158
878
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
204
1292
2.11
12.74
5.1
4.9
mmol/l
1.2
1.2
0.21
170
1076
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
319
2434
2.25
11.76
6.0
6.2
u/l
69.6
73.0
1.38
309
2278
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
112
576
2.28
11.69
1.8
1.5
pmol/l
434.0
58447022.7
1.34
101
515
(3019309) Folate [Moles/volume] in Red Blood Cells
82
387
2.39
10.33
1.7
1.6
nmol/l
1271.3
1160.1
0.42
67
302
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
14
20
7.20
9.34
3.5
2.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
173
1134
1.89
8.93
4.9
4.3
mmol/l
1.2
1.2
0.37
157
1027
(3013826) Glucose [Moles/volume] in Serum or Plasma
235
1697
1.86
8.92
4.4
3.5
mmol/l
6.3
6.2
0.35
210
1504
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
163
1068
1.85
8.29
1.8
1.8
pmol/l
99.3
98.1
0.13
94
568
(3021960) Folate [Moles/volume] in Serum or Plasma
105
598
2.00
8.12
1.6
1.4
nmol/l
20.6
21.6
0.31
95
523
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
173
1163
1.82
8.04
2.9
2.9
u/l
28.6
27.6
0.19
164
1116
(3028707) Methadone [Presence] in Urine by Screen method
31
102
3.20
7.75
2.7
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
161
1076
1.80
7.52
1.8
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
78
418
2.06
7.07
2.3
2.2
u/l
5970.4
4610.0
0.18
35
184
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
378
3304
2.30
6.98
4.4
3.4
mmol/l
5.7
5.6
0.99
355
3101
(4198724)
12
20
6.15
6.94
1.7
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
147
976
1.77
6.91
3.0
2.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
308
2539
1.77
6.41
3.3
2.6
u/l
32.0
32.8
0.11
295
2425
(3019550) Sodium [Moles/volume] in Serum or Plasma
386
3446
2.31
6.05
12.5
8.6
mmol/l
139.3
139.6
1.85
381
3349
(3018418) pH of Serum or Plasma
118
760
1.77
6.04
4.1
3.2
ph
7.4
7.4
0.20
24
149
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
356
3087
1.94
6.04
6.2
4.4
pmol/l
14.0
14.3
1.40
342
2916
(3002032) Base excess in Venous blood by calculation
35
142
2.60
6.03
2.3
3.3
mmol/l
0.9
2.2
0.79
25
113
(3023368) Bacteria identified in Blood by Culture
93
560
1.85
5.94
4.0
3.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
136
917
1.71
5.89
2.7
2.6
ng/l
20.7
18.4
0.10
59
397
(3031040) Bacteria [#/volume] in Urine by Automated count
292
2397
1.70
5.89
5.3
3.7
e6/l
7021.0
960.5
—
5
28
(3023103) Potassium [Moles/volume] in Serum or Plasma
386
3457
2.27
5.81
12.9
8.7
mmol/l
3.9
3.9
0.21
379
3345
(3026782) Osmolality of Urine
88
524
1.86
5.81
2.9
2.3
mosm/kgh2o
519.8
536.2
0.20
76
440
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
195
1453
1.63
5.71
2.2
2.2
nmol/l
72.7
74.3
0.39
182
1347
(3024561) Albumin [Mass/volume] in Serum or Plasma
157
1119
1.64
5.43
4.3
3.9
g/l
36.1
37.3
1.91
147
1051
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
136
938
1.66
5.33
3.2
2.2
u/l
53.6
54.7
0.15
121
875
(42870588) Differential panel, method unspecified - Blood
145
1027
1.63
5.08
5.4
5.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
36
161
2.35
5.08
3.8
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
59
325
1.95
4.91
1.4
1.9
nmol/l
380.4
369.6
0.14
51
300
(3044889) 12 lead EKG panel
256
2082
1.58
4.91
3.1
2.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
396
3630
2.33
4.85
12.5
9.3
mg/l
19.2
17.5
0.48
319
2745
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
55
298
1.97
4.80
3.5
3.7
pmol/l
4.5
4.7
0.56
46
265
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
386
3514
2.07
4.64
7.2
5.0
mu/l
1.6
2.0
0.79
371
3342
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
116
793
1.64
4.62
1.7
2.0
mg/l
2.8
2.8
0.03
96
675
(3013707) Erythrocyte sedimentation rate by Westergren method
302
2570
1.61
4.62
3.6
3.6
mm/h
10.6
9.0
1.91
288
2411
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
137
979
1.59
4.54
3.8
2.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
217
1721
1.53
4.50
6.1
5.2
e9/l
0.0
0.0
0.28
188
1524
(3019225) pH of Specimen
48
254
2.00
4.48
3.2
3.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
216
1713
1.53
4.47
6.0
5.1
e9/l
0.5
0.5
0.80
187
1525
(3013650) Neutrophils [#/volume] in Blood by Automated count
242
1970
1.53
4.42
9.7
7.7
e9/l
4.2
3.9
1.29
215
1734
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
199
1556
1.52
4.37
4.6
4.9
umol/l
9.0
9.5
0.48
189
1460
(3011397) Hemoglobin [Presence] in Urine by Test strip
109
745
1.62
4.32
4.3
2.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
87
561
1.69
4.31
3.0
2.1
e6/l
8.0
10.1
0.51
75
484
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
220
1761
1.52
4.30
4.8
3.9
—
—
—
0
0
(3015736) pH of Urine
181
1393
1.52
4.25
4.0
2.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
223
1795
1.51
4.22
6.4
5.4
e9/l
0.2
0.2
0.24
199
1615
(3035350) Ketones [Presence] in Urine by Test strip
220
1768
1.51
4.18
4.6
2.9
estimate
0.0
0.0
0.00
46
374
(3018095) Leukocytes [#/volume] in Urine
146
1079
1.54
4.11
3.7
2.9
e6/l
24.5
58.7
1.33
99
667
(3019150) Specific gravity of Urine by Refractometry
108
746
1.60
4.07
5.3
3.0
kg/l
1.0
1.0
0.16
16
101
(3037467) Urinalysis macro (dipstick) panel - Urine
292
2498
1.54
4.07
4.9
3.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
203
1612
1.50
4.04
5.7
5.3
%
7.8
7.8
0.04
194
1519
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
441
1.73
4.02
1.9
2.1
mmol/l
2.4
2.4
0.28
63
380
(3002582) Erythrocytes [#/volume] in Urine
117
827
1.57
4.00
3.3
2.5
e6/l
14.0
79.8
1.16
96
604
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
114
804
1.57
3.92
1.8
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
220
1783
1.48
3.92
6.3
5.1
e9/l
2.1
2.0
0.17
195
1612
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
49
274
1.89
3.91
2.5
2.2
u/l
36.7
31.7
0.27
44
234
(40758558) Short blood count panel - Blood
115
814
1.57
3.89
5.6
5.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
44
238
1.95
3.87
2.5
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
37
188
2.06
3.86
2.6
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
26
116
2.32
3.72
5.8
7.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
44
242
1.91
3.69
2.5
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
143
2.18
3.69
1.7
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
200
1604
1.47
3.68
5.5
5.1
%
2.6
2.7
0.12
189
1498
(3012095) Magnesium [Moles/volume] in Serum or Plasma
62
380
1.74
3.68
3.4
2.5
mmol/l
0.8
0.8
3.26
57
361
(3018010) Neutrophils/100 leukocytes in Blood
206
1666
1.46
3.61
5.8
4.9
%
56.6
56.5
0.05
194
1566
(3021589) Normoblasts [#/volume] in Blood
192
1534
1.46
3.58
8.7
7.3
e9/l
0.0
0.0
0.66
153
1286
(3015235) Bicarbonate [Moles/volume] in Capillary blood
14
46
3.11
3.56
2.1
2.0
mmol/l
22.5
24.1
0.47
14
41
(3019832) Treponema pallidum Ab [Presence] in Serum
130
963
1.50
3.53
1.8
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
207
1681
1.45
3.52
5.4
5.1
%
30.1
29.8
0.15
196
1578
(3027008) Opiates [Presence] in Urine
43
239
1.89
3.50
2.3
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
216
1772
1.45
3.46
5.5
4.1
estimate
0.0
0.0
0.50
49
385
(3016879) Cocaine [Presence] in Urine
40
218
1.92
3.46
2.5
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
147
1121
1.48
3.45
1.9
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
218
1794
1.44
3.42
4.5
3.0
estimate
0.0
0.0
0.50
48
375
(3022096) Basophils/100 leukocytes in Blood
191
1536
1.44
3.38
5.6
5.2
%
0.6
0.7
0.47
181
1431
(3001122) Ferritin [Mass/volume] in Serum or Plasma
245
2064
1.44
3.36
3.2
2.8
ug/l
63.6
58.6
0.30
232
1957
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
402
3781
2.17
3.36
10.0
8.0
u/l
22.4
23.6
1.13
396
3674
(3003694) ABO and Rh group [Type] in Blood
169
1331
1.45
3.34
1.8
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
56
344
1.72
3.30
1.9
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
116
2.23
3.29
1.8
3.0
mmol/l
2.3
0.8
0.55
15
83
(3026389) Candida sp identified in Specimen by Organism specific culture
13
43
3.09
3.28
1.2
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
374
3445
1.71
3.27
3.9
3.4
mmol/l
4.8
4.8
0.04
348
3284
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
373
3434
1.70
3.26
3.8
3.4
mmol/l
1.5
1.6
4.28
349
3263
(3029937) Albumin [Presence] in Urine by Test strip
127
955
1.47
3.16
5.3
3.1
estimate
0.0
0.0
0.80
46
385
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
37
203
1.90
3.15
5.9
3.3
mmol/l
1.2
1.2
0.89
28
170
(3003458) Phosphate [Moles/volume] in Serum or Plasma
45
263
1.80
3.15
6.2
4.6
mmol/l
1.1
1.0
0.82
40
242
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
25
121
2.13
2.99
1.8
3.0
kpa
5.0
5.1
0.13
25
115
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
37
208
1.85
2.93
1.4
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
68
454
1.59
2.92
1.9
2.5
ng/l
605.2
545.6
0.09
51
366
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
86
606
1.53
2.92
2.4
2.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
101
738
1.48
2.88
3.4
2.4
e6/l
0.2
0.3
0.39
83
532
(3017143) Hepatitis C virus Ab [Presence] in Serum
84
592
1.52
2.85
1.7
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
374
3473
1.64
2.81
4.2
3.7
mmol/l
2.9
2.9
0.19
346
3289
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
37
213
1.81
2.73
1.9
2.3
g/l
0.2
0.2
0.48
32
207
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
214
1.80
2.70
1.4
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
40
237
1.76
2.69
2.4
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
357
3290
1.53
2.66
3.5
3.1
mmol/l
1.3
1.2
3.04
333
3114
(3034274) Bile acid [Moles/volume] in Serum --fasting
24
121
2.04
2.61
1.4
2.2
umol/l
4.4
5.2
0.51
19
89
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
18
81
2.28
2.57
1.6
2.5
%
1.6
1.2
0.39
18
81
(46235355) HIV 1 and 2 tests - Meaningful Use set
164
1334
1.37
2.54
2.4
2.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
95
2.16
2.53
3.7
5.0
mmol/l
23.8
24.9
0.79
20
95
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
326
2965
1.43
2.47
5.4
4.1
mmol/mol
37.5
37.4
0.08
309
2820
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
21
3.86
2.47
1.4
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
101
760
1.43
2.45
3.3
2.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
62
423
1.55
2.43
2.8
2.0
umol/l
14.1
15.0
0.36
57
382
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
171
1409
1.36
2.41
4.7
3.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
97
2.11
2.41
1.2
1.7
—
—
—
0
0
(3013512) EKG study
95
709
1.44
2.41
3.1
2.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
27
3.38
2.40
1.7
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
101
768
1.41
2.31
3.8
2.9
mmol/l
6.3
7.6
2.17
84
660
(3023323) Follitropin [Units/volume] in Serum or Plasma
60
414
1.52
2.25
1.3
1.3
iu/l
25.1
24.4
0.05
52
363
(3004789) Transferrin [Mass/volume] in Serum or Plasma
55
373
1.55
2.23
2.9
2.0
g/l
2.7
2.5
1.02
46
337
(21494755) Public health laboratory ask at order entry panel
38
587
0.61
2.21
1.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
52
349
1.56
2.20
1.5
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
31
184
1.74
2.11
2.6
3.5
ng/l
70.0
70.3
0.01
26
168
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
49
328
1.56
2.10
3.0
2.1
%
21.5
24.2
0.61
42
271
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
53
364
1.52
2.04
1.5
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
1042
1.34
2.02
1.4
1.3
u/ml
0.6
2.0
1.78
47
293
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
52
357
1.52
2.00
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
52
357
1.52
2.00
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
52
358
1.52
1.98
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
52
358
1.52
1.98
1.4
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
26
150
1.78
1.95
4.6
7.0
%
97.0
96.8
0.15
26
145
(3024928) Oxygen saturation in Venous blood
8
27
3.00
1.94
1.5
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
114
1.89
1.91
2.4
2.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
353
3302
1.41
1.90
9.8
7.6
ml/min/173m2
93.7
93.2
0.18
287
2641
(3021387) Prolactin [Units/volume] in Serum or Plasma
42
279
1.56
1.88
1.4
1.5
mu/l
476.2
288.6
0.99
37
244
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
41
271
1.57
1.87
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
126
1025
1.33
1.86
2.7
2.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
18
94
1.96
1.83
5.4
8.6
%
94.9
95.1
0.13
18
94
(3022313) Gas panel - Capillary blood
16
80
2.04
1.82
1.8
3.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
85
654
1.37
1.80
1.5
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
28
171
1.68
1.75
4.7
6.6
mmol/l
0.4
1.3
0.57
22
127
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
36
2.53
1.75
1.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
156
1.71
1.73
1.3
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
30
2.70
1.73
1.9
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
96
758
1.34
1.73
1.8
1.9
u/l
240.5
206.4
0.08
91
724
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
24
2.95
1.73
1.0
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
13
3.88
1.72
1.2
1.7
nmol/l
156.4
148.2
—
5
13
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
46
319
1.50
1.71
8.2
4.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
25
149
1.72
1.71
12.5
7.5
mmol/l
7.1
6.7
0.14
25
144
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
90
1.93
1.67
1.7
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
25
2.83
1.65
1.1
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
109
886
1.31
1.60
5.2
5.2
inr
1.0
1.0
1.63
33
323
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
25
152
1.69
1.60
1.6
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
402
3881
1.66
1.59
13.1
9.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
23
138
1.70
1.55
1.3
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
419
4110
2.38
1.55
20.9
14.2
e9/l
272.2
268.3
0.60
413
4039
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
58
2.10
1.50
1.1
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
37
2.46
1.48
1.1
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
47
338
1.44
1.48
2.0
2.4
umol/l
4.7
5.0
0.17
38
295
(3013290) Carbon dioxide [Partial pressure] in Blood
10
45
2.25
1.47
4.9
1.9
kpa
5.0
5.0
—
10
45
(1616796) Gas panel - Central venous blood
10
45
2.25
1.47
2.9
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
10
45
2.25
1.47
4.9
1.9
kpa
9.6
9.7
—
10
45
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
10
45
2.25
1.47
1.8
2.8
ug/min
21.6
123.2
—
5
30
(40761536) Microorganisms panel - Urine sediment
47
339
1.43
1.46
4.9
3.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
28
2.52
1.45
1.0
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
42
297
1.46
1.44
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
113
936
1.28
1.44
4.8
3.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
419
4113
2.33
1.42
20.8
14.2
e12/l
4.4
4.5
2.50
410
4034
(3001019) Free T4 and TSH panel - Serum or Plasma
28
416
0.65
1.40
2.1
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
57
429
1.38
1.40
1.3
1.2
iu/ml
77.3
164.5
1.97
29
182
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
266
1.47
1.38
3.0
2.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
82
1.86
1.37
4.8
8.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
41
292
1.45
1.37
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
41
293
1.44
1.34
1.5
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
34
234
1.49
1.34
2.6
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
57
434
1.36
1.31
1.5
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
419
4115
2.29
1.29
20.9
14.2
e9/l
7.0
6.7
2.29
412
4032
(3007164) IgA [Mass/volume] in Serum or Plasma
105
874
1.27
1.28
1.4
1.3
g/l
2.2
2.0
0.95
67
565
(40761535) Cells panel - Urine sediment
32
221
1.48
1.25
4.9
3.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
26
172
1.54
1.24
4.9
6.5
kpa
12.4
13.4
0.69
26
165
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
26
172
1.54
1.24
4.9
6.5
kpa
5.3
5.1
0.46
26
165
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
51
387
1.36
1.21
1.5
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
41
301
1.40
1.18
1.6
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
34
241
1.45
1.18
1.1
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
16
95
1.71
1.15
9.1
1.9
g/l
3.6
3.6
0.01
16
90
(3027945) Reticulocytes/100 erythrocytes in Blood
31
217
1.46
1.15
2.7
2.2
%
1.6
1.7
0.70
24
192
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
110
934
1.24
1.13
2.7
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
31
2.28
1.11
1.0
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
14
81
1.75
1.10
1.5
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
1.0
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
21
2.40
1.09
1.0
1.1
miu/ml
1208.0
1843.5
—
5
21
(3000492) Spirometry study
25
357
0.68
1.06
1.4
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
80
661
1.26
1.04
5.2
4.0
mg/mmol
17.3
9.2
0.27
49
411
(3042631) Mycobacterium sp identified in Specimen
5
22
2.29
1.03
2.0
2.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
131
1.55
1.01
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
87
729
1.24
1.01
1.3
1.3
iu/ml
14.3
25.2
2.20
29
234
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
76
1.73
1.00
1.4
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
356
1.33
0.98
1.5
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
50
1.82
0.97
2.6
3.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
32
0.00
0.95
0.0
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
117
1.56
0.95
1.1
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
55
1.84
0.93
1.1
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
76
634
1.24
0.92
3.9
3.2
mg/l
112.3
173.1
0.18
43
402
(44790048)
6
28
2.16
0.92
1.2
1.3
—
—
—
0
0
(44790047)
6
28
2.16
0.92
1.2
1.3
—
—
—
0
0
(44806118)
6
28
2.16
0.92
1.2
1.3
—
—
—
0
0
(44790049)
6
28
2.16
0.92
1.2
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
102
1.59
0.91
2.1
3.2
g/l
0.4
0.1
—
5
32
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
132
1165
1.19
0.91
1.8
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
94
804
1.22
0.90
2.0
1.6
mg/l
1.0
0.7
0.81
70
592
(3003327) Ova and parasites identified in Stool by Light microscopy
23
161
1.45
0.88
1.6
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
120
1.52
0.87
1.1
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
10
165
0.60
0.83
1.4
1.4
pmol/l
68.4
64.0
—
10
160
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
277
1.33
0.82
1.7
1.4
—
—
—
0
0
(44813793)
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
11
66
1.68
0.79
5.8
5.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
50
405
1.27
0.79
2.1
2.7
ng/l
155.7
404.9
0.45
21
193
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
85
730
1.21
0.79
1.2
1.3
u/ml
6.2
9.6
0.31
38
319
(3037522) Nuclear Ab [Titer] in Serum
68
571
1.23
0.79
1.3
1.4
titre
1053.3
574.6
—
9
118
(36660697) Celiac disease serology panel - Serum
46
369
1.28
0.78
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
96
835
1.19
0.78
1.6
1.6
mmol/l
1.4
1.3
0.25
82
732
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
30
227
1.35
0.77
1.5
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
34
1.78
0.76
1.2
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
29
219
1.35
0.75
11.9
9.2
inr
1.3
1.1
—
6
47
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
116
1.48
0.75
1.1
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
24
2.10
0.74
1.2
2.1
mmol/l
3.9
3.9
—
5
24
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
24
2.10
0.74
1.2
2.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
24
2.10
0.74
1.2
2.1
mmol/l
108.2
105.5
—
5
24
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
24
2.10
0.74
1.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
36
282
1.30
0.74
1.5
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
38
1.86
0.74
1.1
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
76
1.60
0.72
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
9
57
1.59
0.71
1.7
1.8
ug/l
311.9
197.9
—
9
46
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
57
1.59
0.71
1.2
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
336
3236
1.18
0.71
16.4
10.9
%
13.4
13.5
0.71
329
3187
(3026493) Urate [Moles/volume] in Serum or Plasma
84
729
1.19
0.70
2.3
2.1
umol/l
4052.4
4622.4
0.05
72
663
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
41
1.72
0.70
1.0
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
77
1.57
0.69
1.1
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
78
674
1.19
0.69
1.4
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
42
1.68
0.68
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
42
1.68
0.68
1.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
42
1.68
0.68
1.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
1.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
1.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
145
1.40
0.67
1.7
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
39
314
1.27
0.66
1.6
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
28
1.79
0.66
1.0
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
28
1.79
0.66
3.2
3.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
28
1.79
0.66
3.0
1.2
pg
33.6
32.4
—
5
28
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
11
70
1.59
0.65
1.5
1.3
u/ml
69.2
123.9
—
5
17
(3005570) Glucose [Moles/volume] in Urine
7
44
1.60
0.65
2.7
2.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
44
1.60
0.65
1.0
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
155
1.37
0.64
1.3
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
80
1.51
0.60
1.4
2.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
47
393
1.22
0.59
2.5
2.2
e6/l
5.0
4.6
0.08
28
198
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.0
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
54
1.49
0.57
1.5
1.4
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
6
36
1.68
0.57
2.2
3.7
mu/l
24.1
26.5
—
6
36
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
159
1.34
0.56
1.5
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
90
1.46
0.56
1.2
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
43
359
1.22
0.55
1.9
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
82
1.48
0.55
2.7
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
135
1241
1.13
0.53
1.4
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
64
558
1.17
0.53
1.9
2.3
ug/g
74.7
78.6
0.13
50
429
(40768793) Breast Pathology biopsy report
9
135
0.66
0.52
1.3
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
40
1.51
0.52
1.3
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
64
1.41
0.51
1.4
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
19
144
1.33
0.51
2.5
2.4
e9/l
62.8
76.9
1.24
11
99
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
474
0.83
0.51
1.4
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
65
1.39
0.51
1.3
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
67
1.50
0.50
1.2
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
48
411
1.19
0.49
2.7
2.1
e6/l
0.6
1.0
0.67
29
216
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
11
76
1.46
0.48
1.8
3.5
mmol/l
24.9
24.5
0.11
11
76
(3044290) Cell count panel - Cerebral spinal fluid
11
76
1.46
0.48
1.2
1.2
—
—
—
0
0
(4268621)
7
46
1.53
0.48
2.0
2.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
32
264
1.23
0.47
1.6
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
118
1087
1.12
0.45
4.0
2.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
51
1.38
0.44
1.3
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
51
1.38
0.44
1.4
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
141
1.29
0.41
2.2
2.0
iu/l
5.4
5.6
—
7
56
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
17
0.00
0.40
0.0
2.6
—
56.0
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
224
1.22
0.39
2.7
1.9
ml/min/173m2
71.0
82.4
0.64
14
90
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
67
1.35
0.38
2.7
2.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
89
1.36
0.38
4.0
4.7
—
—
—
0
0
(4010399)
15
191
0.78
0.37
1.4
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
9
69
1.31
0.37
2.0
3.6
%
1.3
1.6
—
9
64
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
342
0.84
0.37
1.2
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
71
1.27
0.36
1.1
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
274
1.18
0.35
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
45
1.34
0.34
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
45
1.34
0.34
1.0
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
47
1.28
0.32
1.5
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
128
1.26
0.32
1.4
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
128
1.26
0.32
1.4
2.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
12
92
1.31
0.32
1.2
1.3
mg/l
326.3
362.1
0.65
12
85
(4034850)
13
101
1.30
0.32
17.2
6.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
249
1.18
0.31
1.5
1.4
miu/ml
190.4
245.7
0.37
17
134
(3032773) Endomysium IgG Ab [Titer] in Serum
7
52
1.35
0.31
1.1
1.0
—
—
—
0
0
(4094501)
7
53
1.33
0.31
1.1
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
41
363
1.14
0.31
1.1
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
346
1.14
0.29
3.6
3.2
%
29.6
32.5
0.98
33
248
(3014051) Protein [Presence] in Urine by Test strip
8
63
1.27
0.28
1.4
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
120
0.74
0.27
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
57
521
1.11
0.27
2.0
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
11
86
1.29
0.26
1.1
1.1
u/ml
2.3
2.6
—
6
49
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
77
1.31
0.26
1.3
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
71
0.70
0.26
1.0
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
123
1.23
0.25
1.2
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
208
1.16
0.24
3.6
2.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
149
1554
0.94
0.24
1.7
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
72
671
1.09
0.23
2.3
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
316
3215
0.93
0.23
4.1
3.9
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
40
1.25
0.22
1.2
1.1
g/l
1.7
1.4
—
5
35
(3002256) Pathology report gross observation
49
450
1.10
0.22
1.2
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
124
0.80
0.22
2.5
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
1.6
—
0
13
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
7.9
—
0
13
(3010503) CD19 cells [#/volume] in Blood
0
14
0.00
0.20
0.0
2.8
—
0.2
—
0
14
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
27
302
0.89
0.20
2.3
2.2
—
22.4
—
0
22
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
46
427
1.09
0.17
1.1
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
62
1.13
0.17
1.3
1.1
%
131.7
118.0
—
7
56
(4306422)
7
62
1.13
0.17
1.3
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
131
0.84
0.17
3.0
2.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
69
1.16
0.16
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
70
1.15
0.16
1.4
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
8
70
1.15
0.16
4.0
4.2
mmol/l
1.0
1.1
—
8
60
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
70
1.15
0.16
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
11
92
1.20
0.16
1.1
1.4
ug/g
274.8
314.8
—
5
45
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
76
0.79
0.15
3.8
3.6
%
57.2
57.7
—
6
76
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
117
0.85
0.13
1.4
1.8
—
—
—
0
0
(1002224) Polysomnography panel
19
172
1.11
0.11
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
125
0.88
0.10
1.2
1.7
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
45
1.11
0.10
1.4
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
55
1.09
0.09
12.8
1.7
nmol/l
1.0
0.9
—
6
45
(3017181) Myelocytes/100 leukocytes in Blood
27
253
1.07
0.08
6.2
4.0
%
0.8
1.0
—
8
59
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
74
0.81
0.07
3.5
3.3
e9/l
4.2
4.5
—
6
74
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
77
1.04
0.07
1.3
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
28
267
1.05
0.05
2.4
2.2
e9/l
4.1
4.1
0.00
19
226
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
13
141
0.92
0.05
1.3
1.5
g/l
1.2
1.2
0.17
13
133
(3008898) HLA-B27 [Presence]
22
232
0.95
0.05
1.0
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
25
240
1.04
0.03
1.0
1.1
—
172.9
—
0
7
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
16
151
1.06
0.03
1.3
1.3
ug/l
2.5
2.8
0.11
16
136
(3009542) Hematocrit [Volume Fraction] of Blood
355
3538
1.02
0.03
13.4
9.9
%
39.0
39.7
1.04
268
2926
(3025159) Blasts/100 leukocytes in Blood
24
231
1.04
0.03
6.7
4.2
%
0.0
0.2
—
7
42
(3021440) Promyelocytes/100 leukocytes in Blood
25
241
1.04
0.02
6.6
4.1
%
0.0
0.2
—
7
53
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
27
277
0.97
0.01
1.2
1.2
—
20.0
—
0
11
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
176
0.96
0.00
2.7
2.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
276
0.98
0.00
1.0
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
330
3306
0.99
0.00
17.4
11.7
g/l
332.5
332.0
0.48
330
3280
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
125
1.04
0.00
1.5
1.9
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
13
134
0.97
0.00
1.3
1.5
g/l
0.2
0.2
0.20
13
127
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
127
1.02
0.00
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
102
0.98
0.00
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
102
0.98
0.00
1.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
12
118
1.02
0.00
1.2
1.3
—
34.1
—
0
8
(1761868) Lipid panel - Serum or Plasma
149
1491
1.00
0.00
2.6
2.2
—
—
—
0
0
(4035726)
24
243
0.99
0.00
1.3
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
24
236
1.02
0.00
5.5
4.0
%
0.4
0.8
—
7
40
(3049717) Cytology report of Urine Cyto stain
5
55
0.91
0.00
1.4
2.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.3
—
0
5
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
7
0.00
0.00
0.0
1.1
—
150.8
—
0
7
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
3.5
—
314.7
—
0
6
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
50
1.00
0.00
6.4
2.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
2.3
—
0
5
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
3.6
—
0
6
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
69
1.01
0.00
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
60
1.00
0.00
1.2
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
25.0
—
0
8
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
6
0.00
0.00
0.0
3.3
—
7.0
—
0
6
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
35.0
—
0
5
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
88
0.91
0.00
1.4
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
82
0.98
0.00
1.5
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: F5_MENTPUER – Mental and behavioural disorders associated with the puerperium

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).